Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
2,642,815
-
Shares change
-
+2,613,815
-
Total reported value, excl. options
-
$15,502,000
-
Value change
-
+$15,093,000
-
Number of buys
-
7
-
Price
-
$13.92
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q1 2014
As of 31 Mar 2014 REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,642,815 shares of stock of the company.
Largest 8 holders included SPHERA FUNDS MANAGEMENT LTD., ORBIMED ADVISORS LLC, Broadfin Capital, LLC, GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC, UBS AG, and CITIGROUP INC.
This table shows 8 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.